Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$27,257,049
+$5,894,471 QoQ
Shares Held
22,725
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.20%
of 13F equity value
Holder Rank
#754
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essex Financial Services, Inc. holds $71,369,097 across 13 Drug Manufacturers - General names. LLY ranks #1 (38.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
22,725 | $27,257,049 | |
| 2 | JNJ |
Johnson & Johnson
|
60,120 | $15,268,676 | |
| 3 | ABBV |
AbbVie Inc.
|
35,746 | $8,995,123 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,212 | $5,552,742 | |
| 5 | PFE |
Pfizer Inc
|
185,560 | $4,468,284 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
51,332 | $2,957,749 | |
| 7 | AMGN |
Amgen Inc
|
6,773 | $2,452,638 | |
| 8 | NVS |
Novartis AG
|
8,976 | $1,406,718 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,257,049 | 22,725 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $21,362,578 | 23,226 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $24,954,071 | 23,220 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $17,871,749 | 23,423 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $18,841,240 | 24,170 | Shares | Defined | 2025-07-16 | |
| 2025-03-31 | $20,720,430 | 25,088 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $20,094,388 | 26,029 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $23,129,235 | 26,107 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $25,570,647 | 28,243 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $20,714,740 | 26,627 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $14,620,216 | 25,081 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $13,622,691 | 25,362 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $12,019,019 | 25,628 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $8,650,749 | 25,190 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,385,991 | 25,656 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $8,156,180 | 25,224 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $8,203,991 | 25,303 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $7,209,937 | 25,177 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $6,405,541 | 23,190 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,554,210 | 24,039 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,774,034 | 25,157 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $4,699,830 | 25,157 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,349,656 | 25,762 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,474,029 | 23,470 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,489,645 | 21,255 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,211,506 | 23,151 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||